FDA Clears Ultrasound-Guided Ablation for Benign Thyroid Nodules

FDA has cleared an ultrasound-guided ablation system for treating benign thyroid nodules in adults, offering a non-surgical alternative to traditional surgery or active surveillance.

• The clearance expands interventional radiology options for managing symptomatic or enlarging benign thyroid nodules.
• This minimally invasive approach aims to reduce nodule volume and related compressive symptoms.
• Specific device name, manufacturer, and predicate details were not provided in the source.

RadPigeon summaries are original and for information only. They are not clinical advice.